History & Overview Annual Report President's Pages Center News Community Affairs
Make a Gift Cycle for Survival Fred's Team Rock & Run on the River Yankees Universe Fund Thomas Blake Sr. Memorial Research Fund Donating Blood & Platelets Volunteering Thrift Shop Park Avenue Potluck CELEBRATIONS
Press Releases In the News Information for Journalists News@MSKCC
Manhattan New Jersey Long Island Westchester
Working at Memorial Sloan-Kettering Work Sites College Recruitment About Nursing Job Fairs & Career Days IS Careers Job Search & Apply Online
Making an Appointment

Murray F. Brennan, MD, FACS

Murray F. Brennan
Murray F. Brennan, MD, FACS
Benno C. Schmidt Chair in Clinical Oncology
Dr. Brennan is a surgeon with special expertise in the treatment of soft tissue sarcomas, endocrine tumors (those that involve the adrenal gland, thyroid gland, parathyroid, and the pancreatic islet cells), and pancreatic and stomach cancers. He was Chairman of the Department of Surgery from 1985 until June 2006. He continues in active practice.

Dr. Brennan works closely with a team of radiologists, pathologists, medical oncologists, and radiation oncologists to provide treatments that are individually tailored to each patient. Throughout his career, his clinical and research interests have focused on surgical oncology, endocrinology, metabolism, and nutrition. He has designed and conducted numerous clinical trials, which have produced major findings in the management of patients with soft tissue sarcomas and pancreatic cancer.

Together with his colleagues, Dr. Brennan has created the world's largest database of sarcoma patients. This database includes important data on some 7,000 patients treated at MSKCC since 1982, such as age at diagnosis, tumor size, histologic grade and subtype, and tumor depth and location. Based on this extensive information, they have developed a computer program that is highly effective in predicting patients' chances of surviving soft tissue sarcoma for at least 12 years after their diagnosis. This program, called a nomogram, may help doctors better design treatment to ensure that patients at greatest risk of recurrence can be treated more aggressively, while patients at low risk can avoid unnecessary additional treatment.

Dr. Brennan has lectured throughout the world and authored or co-authored more than 1,000 scientific papers and book chapters, as well as a book on soft tissue sarcoma. Over the years, he has served as Director of the American Board of Surgery, Chairman of the American College of Surgeons Commission on Cancer, President of the Society of Surgical Oncology, Vice President of the American College of Surgeons, and President of the American Surgical Association, the oldest and most prestigious surgical association in the United States. Dr. Brennan has been awarded Honorary Fellowship in the Royal College of Surgeons in Ireland, the Royal College of Surgeons of Edinburgh and England, the Royal Australasian College of Surgeons, and the Royal College of Physicians and Surgeons of Glasgow and Canada. In 1995, Dr. Brennan was honored with membership in the Institute of Medicine of the National Academy of Sciences, and in 2000 he received the American College of Surgeons' highest award, the Distinguished Service Award.
Appointments for New Patients
646-497-9072

Phone
212-639-6586

Education
MD, University of Otago (New Zealand)

Residencies
University of Otago; Peter Bent Brigham Hospital/Harvard Medical School

Fellowships
Peter Bent Brigham Hospital/Harvard Medical School

Board Certifications
Surgery

Clinical Expertise
General Surgical Oncology; Pancreatic Cancer; Gastric Cancer: adenocarcinoma; Soft Tissue Sarcoma; Endocrine Tumors: thyroid, parathyroid, neuroendocrine tumors, multiple endocrine neoplasia, adrenocortical carcinoma, carcinoid tumor, and pheochromocytoma.

Department & Service


Bookmark and SharePrintEmail This Page